Engagement in Group Psychotherapy Among Marginalized Individuals With Hepatitis C

REFERENCES

• Acejas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18(5), 352–358.
   PubMed Web of Science ®Google Scholar
• Bernard, H., Burlingame, G., Flores, P., Greene, L., Joyce, A., Kobos, J. C., … Feirman, D. (2008). Clinical practice guidelines for group psychotherapy. International Journal of Group Psychotherapy, 58(4), 455–542.
   PubMed Web of Science ®Google Scholar
• Burns, D., & Nolen-Hoeksema, S. (1992). Therapeutic empathy and recovery from depression in cognitive-behavioral therapy: A structural equation model. Journal of Consulting Clinical Psychology, 60(3), 441–449.
   PubMed Web of Science ®Google Scholar
• Charlebois, A., Lee, L., Cooper, E., Mason, K., & Powis, J. (2012). Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients. Journal of Viral Hepatitis, 19(12), 836–842.
   PubMed Web of Science ®Google Scholar
• Crone, C., & Gabriel, G. (2003). Comprehensive review of hepatitis C for psychiatrists: Risks, screening, diagnosis, treatment and interferon-based therapy complications. Journal of Psychiatric Practice, 9(20), 93–110.
   PubMedGoogle Scholar
• Erim,Y., Tagay, S., Beckmann, M., Bein, S., Cicinnati, V., Meckebaum, S., … Schlaak, J. F. (2010). Depression and protective factors of mental health in people with hepatitis C: A questionnaire survey. International Journal of Nursing Studies, 47(3), 342–349.
   PubMed Web of Science ®Google Scholar
• Freire, P. (1973). Education for critical consciousness. New York, NY: Seabury.
   Google Scholar
• Grebely, J., de Vlaming, S., Duncan F., Vilijoen, M., & Conway, B. (2008). Current approaches to HCV infection in current and former injection drug users. Journal of Addictive Diseases, 27(2), 25–35.
   PubMed Web of Science ®Google Scholar
• Grebely, J., Raffa, J. D., Lai, C., Krajden, M., Kerr, T., Fischer, B., & Tyndall, M. W. (2009). Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. Journal of Viral Hepatitis, 16(5), 352–358.
   PubMed Web of Science ®Google Scholar
• Grebely, J., Knight, E., Genoway, K. A., Viljoen, M., Khara, M., Elliott, D., … Conway, B. (2010). Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support. European Journal of Gastroenterology & Hepatology, 22(3), 270–277.
   PubMed Web of Science ®Google Scholar
• Hardin, J., & Hilbe, J. (2012). Generalized estimating equations (2nd ed.). Boca Raton, FL: Chapman Hall.
   Google Scholar
• Heckbert, S. R., Rutter, C. M., Oliver, M., Williams, L. H., Ciechanowski, P., Lin, E. H., … Von Korff, M. (2010). Depression in relation to long-term control of glycemia, blood pressure, and lipids in patients with diabetes. Journal of General Internal Medicine, 25(6), 524–529.
   PubMed Web of Science ®Google Scholar
• Holzapfel, N., Zugck, C., Muller-Tasch, T., Lowe, B., & Wild, B. (2007). Routine screening for depression and quality of life in outpatients with congestive heart failure. Psychosomatics, 48(2), 112–116.
   PubMed Web of Science ®Google Scholar
• Iversen, J., Grebely, J., Topp, L., Wand, H., Dore, G., & Maher, L. (2014). Uptake of hepatitis C treatment among people who inject drugs attending needle and syringe programs in Australia, 1999–2011. Journal of Viral Hepatitis, 21(3), 198–207.
   PubMed Web of Science ®Google Scholar
• Liang, K.-Y., & Zeger, S. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73(1), 13–22.
   Web of Science ®Google Scholar
• Lese, K., & Macnair-Semands, R. (2000). The Therapeutic Factors Inventory: Development of a scale. Group, 24(4), 303–317.
   Google Scholar
• Liu, S. S., Schneekloth, T. D., & Talwalker, J. A. (2010). Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. Canadian Journal of Clinical Gastroenterology, 44(8), 178–185.
   Web of Science ®Google Scholar
• Macnair-Semands, R., & Lese, K. (2000). Interpersonal problems and the perception of therapeutic factors in group therapy. Small Group Research, 31(2), 158–174.
   Web of Science ®Google Scholar
• Mehta, S. H., Genberg, B. L., Astemborski, J., Kavesery, R., Kirk, G. D., Vlahov, D., … Thomas, D. L. (2008). Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health, 33(3), 126–133.
   PubMed Web of Science ®Google Scholar
• Munoz-Plaza, C., Strauss S., Astone-Twerell, J., Des Jarlais, D., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2008). Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. International Journal of Drug Policy, 19(1), 71–78.
   PubMed Web of Science ®Google Scholar
• Myles, A., Mugford, G. J., Zhao, J., Krahn, M., & Wang, P. P. (2011). Physicians’ attitudes and practice toward treating injection drug users infection with hepatitis C virus: Results from a national specialist survey in Canada. Canadian Journal of Gastroenterology, 25(3), 135–139.
   PubMed Web of Science ®Google Scholar
• Newman, A. I., Beckstead, S., Beking, D., Finch, S., Knorr, T., Lynch, C., … Shore, R. (2013). Treatment of chronic hepatitis C infection among current and former injection drug users within a multidisciplinary treatment model at a community health centre. Canadian Journal of Gastroenterology, 27(4), 217–223.
   PubMed Web of Science ®Google Scholar
• Norcross, J. C., & Wampold, B. E. (2011). Evidence-based therapy relationships: Research conclusions and clinical practices. Psychotherapy (Chic), 48(1), 98–102.
   PubMed Web of Science ®Google Scholar
• Persons, J., & Burns, D. (1985). Mechanisms of action of cognitive therapy: The relative contributions of technical and interpersonal interventions. Cognitive Therapy & Research, 9(5), 539–551.
   Web of Science ®Google Scholar
• Riley, D., Sawka, E., Conley, P., Hewitt, D., Mitic, W., Poulin, … Topp, J. (1999). Harm reduction: Concepts and practice. A policy discussion paper. Substance Use & Misuse, 34(1), 9–24.
   PubMed Web of Science ®Google Scholar
• Schaefer, M., Heinz, A., & Backmund, M. (2004). Treatment of chronic hepatitis C in patients with drug dependence: Time to change the rules? Addiction, 99(9), 1167–1175.
   PubMed Web of Science ®Google Scholar
• Silberbogen, A. K., Ulloa, E. W., Janke, E. A., & Mori, D. L. (2009). Psychosocial issues and mental health treatment recommendations for patients with hepatitis C. Psychosomatics, 50(2), 114–122.
   PubMed Web of Science ®Google Scholar
• Sockalingam, S., & Abbey, S. E. (2009). Managing depression during hepatitis C treatment. Canadian Journal of Psychiatry, 54(9), 614–625.
   PubMed Web of Science ®Google Scholar
• Sockalingam, S., Blank, D., Al Jarad, A., Alosaimi, F., Hirschfield, G., & Abbey, S. E. (2011). A comparison of depression screening instruments in hepatitis C and the impact of depression on somatic symptoms. Psychosomatics, 52(5), 433–440.
   PubMed Web of Science ®Google Scholar
• Sockalingam, S., Shammi, C., & Stergiopoulous, V. (2007). Managing the neuropsychiatric complications of hepatitis C treatment. British Journal of Hospital Medicine (London), 68(10), 520–525.
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. Journal of the American Medical Association, 282(18), 1737–1744
   PubMed Web of Science ®Google Scholar
• Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
   PubMed Web of Science ®Google Scholar
• Strauss, B., Burlingame, G. M., & Bormann, B. (2008). Using the CORE-R battery in group psychotherapy. Journal of Clinical Psychology, 64(11), 1225–1237.
   PubMed Web of Science ®Google Scholar
• Strike, C., Leonard, L., Millson, M., Anstice, S., Berkeley, N., & Medd, E. (2006). Ontario needle exchange programs: Best practice recommendations. Toronto, Canada: Ontario Needle Exchange Coordinating Committee.
   Google Scholar
• Swan, D., Long, J., Carr, M., Flanagan, J., Irish, H., Keating, S. … Cullen, W. (2010). Barriers to and facilitators of hepatitis C testing, management and treatment among current and former injecting drug users: A qualitative exploration. Aids Patient Care and STDs, 24(12), 753–762.
   PubMed Web of Science ®Google Scholar
• Swift, J., & Greenberg, R. (2012). Premature discontinuation in adult psychotherapy: A meta-analysis. Journal of Consulting and Clinical Psychology, 80(4), 547–559.
   PubMed Web of Science ®Google Scholar
• Sylvestre, D. L., & Zweben, J. E. (2007). Integrating HCV services for drug users: A model to improve engagement and outcomes. International Journal of Drug Policy, 18, 406–410.
   PubMed Web of Science ®Google Scholar
• Treloar, C., Rance, J., & Backmund, M. (2013). Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases, 57(S2), S51–55.
   Web of Science ®Google Scholar
• Tschuschke, V., & Dies, R. R. (1994). Intensive analysis of therapeutic factors and outcome in long-term inpatient groups. International Journal of Group Psychotherapy, 44(2), 185–208.
   PubMed Web of Science ®Google Scholar
• Woolhouse, S., Cooper, E., & Pickard, A. (2013). “It gives me a sense of belonging”: Providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group. International Journal of Drug Policy, 24(6), 550–557.
   PubMed Web of Science ®Google Scholar
• Yalom, I., & Leszcz, M. (2005). The theory and practice of group psychotherapy (5th ed.). New York, NY: Basic Books.
   Google Scholar
• Zeremski, M., Zibbell, J., Martinez, A. D., Kritz, S., Smith, B. D., & Talal, A. H. (2013). Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World Journal of Gastroenterology, 19(44), 7846–7851.
   PubMed Web of Science ®Google Scholar